Join the Deep Vein Thrombosis (DVT) group to help and get support from people like you.
Deep Vein Thrombosis (DVT) News
Related terms: Blood clot in the legs, Deep venous thrombosis, Thromboembolism, DVT
Rate of Venous Thromboembolism Increased With Cancer Surgery
FRIDAY, Feb. 2, 2024 – The rate of venous thromboembolism is increased in association with cancer surgery, according to a study published online Feb. 2 in JAMA Network Open. Johan Björklund, M.D., ...
Clot Risk High With Oral Contraceptives for Those at Genetic Risk
FRIDAY, Dec. 1, 2023 – Oral contraceptive (OC) use is associated with an increased risk for developing a venous thromboembolism (VTE), particularly among women with a high genetic predisposition,...
Combo of Certain Birth Control Pills, Painkillers Could Raise Women's Clot Risk
FRIDAY, Sept. 8, 2023 – It's well known that certain forms of birth control carry a small risk of blood clots. Now a large new study suggests that some common painkillers can magnify that risk. The...
Apixaban Has Lower Bleeding Risk for Initial Anticoagulation for Venous Thromboembolism
TUESDAY, Sept. 5, 2023 – Apixaban has a lower bleeding risk than warfarin or rivaroxaban during initial treatment for patients with venous thromboembolism (VTE), according to a study published...
New Report Measures Scope of Damage From Medical Mistakes
THURSDAY, July 20, 2023 – About 795,000 Americans die or are permanently disabled every year due to misdiagnosed medical conditions. A new analysis led by experts at Johns Hopkins Medicine in...
Benefits of Indefinite Anticoagulant Unclear After First VTE
THURSDAY, June 29, 2023 – For patients with a first unprovoked venous thromboembolism (VTE), indefinite anticoagulation prevents some recurrent VTE events but induces additional major bleeding...
FDA Medwatch Alert: Eliquis (apixaban) 5 mg tablets: Recall One Lot- Bottle labeled as Eliquis 5 mg was found to contain Eliquis 2.5 mg tablets
ISSUE: Bristol-Myers Squibb Company is voluntarily recalling one lot (#HN0063) of Eliquis 5 mg tablets to the consumer level. This lot was distributed nationwide in the U.S. to wholesalers and retail...
FDA Medwatch Alert: Heparin: Drug Safety Communication - Important change to heparin container labels to clearly state the total drug strength
ISSUE: FDA is notifying health care professionals, caregivers, and patients about a change to the container and carton labels for heparin products. This label change will require manufacturers of...
FDA Expands Use of Xarelto to Treat, Reduce Recurrence of Blood Clots
November 2, 2012 – The U.S. Food and Drug Administration today expanded the approved use of Xarelto (rivaroxaban) to include treating deep vein thrombosis (DVT) or pulmonary embolism (PE), and to...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Deep Vein Thrombosis - Prophylaxis, Deep Vein Thrombosis - Recurrent Event, Deep Vein Thrombosis - First Event